Degertekin, B. Et Al. 2020. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology , vol.31, no.12 , 883-893.

Degertekin, B., DEMİR, M., Akarca, U. S., KANİ, H. T., Üçbilek, E., Yildirim, E., ... Güzelbulut, F.(2020). Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology , vol.31, no.12, 883-893.

Degertekin, Bülent Et Al. "Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience," Turkish Journal of Gastroenterology , vol.31, no.12, 883-893, 2020

Degertekin, Bülent Et Al. "Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience." Turkish Journal of Gastroenterology , vol.31, no.12, pp.883-893, 2020

Degertekin, B. Et Al. (2020) . "Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience." Turkish Journal of Gastroenterology , vol.31, no.12, pp.883-893.

@article{article, author={Bülent Degertekin Et Al. }, title={Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience}, journal={Turkish Journal of Gastroenterology}, year=2020, pages={883-893} }